Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
Clinical trial NCT04477512 · COMPLETED
Trial details
- NCT number
- NCT04477512
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-19
- Primary completion
- 2021-09-09
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.